FOCUSING ON HOW WE MAKE A CHANGE
The 3rd Health Equity in Clinical Trials Congress draws on expertise from the entire clinical trial ecosystem and provides critical insights to cross-functional sponsor functions. We create internal and external alignment on how to shift the industry forward by sharing best practices and upgrading your health equity tool kit.
The FDA is striving for more representative clinical trials to become the norm, it is imperative that DEI strategies are deployed to ensure safety, efficacy, and generalizability of trial data to the wider population - reinforced by the draft guidance on Diversity Action Plans (DAPs). We share breakthroughs on how corporates meet communities and populations relevant to race and ethnicity, sex and gender, age, geography, disability, LGBTQIA+, and more.
2024 HIGHLIGHTS
Thank you for joining us this year, it was truly a delight to meet with so many industry leaders and disrupters in clinical trials. This gathering has been born and grown through our collaborative network – thank you for your continued support and we hope we can continue to work together to drive action for this critical issue.
NEW FEATURES FOR 2025
REAL WORLD DATA, EPIDEMIOLOGY & STUDY DESIGN TRACK
The afternoons of the Congress will now split into 2 tracks to provide extra insights into the upstream functions defining DEI process for sponsors. Topics will include how to address gaps in data sources for underrepresented populations, how to identify disparities in disease prevalence, and how real-world data can be harnessed to define trial design. Incorporating demographic understanding throughout epidemiology and data science is crucial for scientific goal setting in diversity action plans required by the FDA.
EXCLUSIVE PRE-DAY WORKSHOPS
May 6 will feature as an interactive pre-day workshop that furthers the internal and external alignment of sponsors to address DEI barriers in clinical studies. Receive more in-depth insights, case studies, and use cases of strategy deployment and how DEI measures translate to improved recruitment and retention. Hear how sponsors adapt their initiatives, learn from failures and identify best practices through presentations, panel discussions, and roundtable breakouts.
STARTUPS SHOWCASE
As the health equity industry expands and company partnerships multiply, the value in DEI solutions and businesses is under the scope for commercial potential. We are introducing an innovation showcase that enables emerging companies and vendors with the most unique services to receive exposure to our entire-ecosystem audience and catapult their business development needs.
INVESTORS LUNCH
To match the exponential growth of health equity companies we are inviting investors to understand how to navigate the health equity and clinical trials industry at an exclusive lunch meet and greet. Network with VCs who have invested in health equity businesses and understand the commercial value of DEI services, explore the landscape of health equity and the factors propelling the rapid growth of this sector.
EXPAND YOUR NETWORKING POTENTIAL
PHARMA, BIOTECH & MEDICAL DEVICE COMPANIES
CLINICAL RESEARCH SITES, HCPs & CENTERS OF EXCELLENCE
PATIENT ADVOCACY GROUPS & NON-PROFITS
SERVICE PROVIDERS, START-UPS, VENDORS & CROs
INVESTORS
PAYERS, GOVERNMENT & POLICY MAKERS
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.